Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2005. Start Trial.
Date Value
October 02, 2026 0.4917
October 01, 2026 0.5166
September 30, 2026 0.5083
September 29, 2026 0.5028
September 28, 2026 0.5055
September 25, 2026 0.4973
September 24, 2026 0.5732
September 23, 2026 0.5774
September 22, 2026 0.616
September 21, 2026 0.6492
September 18, 2026 0.6575
September 17, 2026 0.663
September 16, 2026 0.6492
September 15, 2026 0.6409
September 14, 2026 0.6381
September 11, 2026 0.6381
September 10, 2026 0.6547
September 09, 2026 0.6533
September 08, 2026 0.6658
September 04, 2026 0.6547
September 03, 2026 0.6492
September 02, 2026 0.6713
September 01, 2026 0.6796
August 31, 2026 0.6934
August 28, 2026 0.6989
Date Value
August 27, 2026 0.7017
August 26, 2026 0.7017
August 25, 2026 0.7017
August 24, 2026 0.6962
August 21, 2026 0.7155
August 20, 2026 0.7155
August 19, 2026 0.7238
August 18, 2026 0.7155
August 17, 2026 0.7072
August 14, 2026 0.7183
August 13, 2026 0.6851
August 12, 2026 0.7183
August 11, 2026 0.7293
August 10, 2026 0.7183
August 07, 2026 0.71
August 06, 2026 0.6962
August 05, 2026 0.6962
August 04, 2026 0.7072
August 03, 2026 0.7348
July 31, 2026 0.71
July 30, 2026 0.6989
July 29, 2026 0.6851
July 28, 2026 0.6906
July 27, 2026 0.6685
July 24, 2026 0.6658

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 2.628
Alnylam Pharmaceuticals, Inc. 21.70
Savara, Inc. 6.877
Vericel Corp. 5.552
Biogen, Inc. 1.723

Price to Book Value Related Metrics

Price 1.78
Earnings Yield -255.9%
Market Cap 14.69M